Dyslipidaemia and Atherosclerosis: Clinician's Guidelines translates recent guidelines for prevention of cardiovascular disease – the ESC/EAS Joint Guidelines for Management of Dyslipidaemia (2011) – to an accessible ready reference.

The content differentiates lipoproteins containing apolipoproteins B or A and their role in atherosclerosis.

For the clinician, the focus is on which lipids should be analysed for risk estimation, and an overview of primary, secondary and genetic causes of dyslipidaemias. The content summarises lifestyle and pharmacotherapy options for clinical management, lipid treatment targets and practical advice for treating patients.

Authored by leading experts in the field, these guidelines will be an invaluable accessible resource for both primary and secondary care clinicians.

Supported by an Unrestricted Educational Grant from SANOFI and REGENERON.

Features include:
- add your own notes within the content;
- bookmark pages;